Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × ibrutinib × Clear all

NCT03267186 2023-08-01

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02351037 2018-08-14

Study of Ibrutinib in Subjects With Acute Myeloid Leukemia

Phase 2 Terminated

36 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute